- Abstract Number: 2542
La Positive, Ro60 Negative Subset of Primary Sjögren’s Syndrome Is a Reality
- Abstract Number: 985
Labial Salivary Gland Antibody-Secreting Cell Specificity and Characteristics in Sjögren’s Patients
- Abstract Number: 739
Lack of Association Between Esophageal Symptoms and Abnormal Findings in High-Resolution Manometry in a Mexican Mestizo Cohort with Systemic Sclerosis (SSc)
- Abstract Number: 1637
LACK of Association of ANTI CCP and Arthritis in SLE
- Abstract Number: 1219
Lack of Gene-Diuretic Interactions on Risk of Incident Gout: The Nurses’ Health Study and Health Professionals Follow-up Study
- Abstract Number: 639
Lack of Response Gene to Complement-32 Impairs Th17 Differentiation and Attenuates Lupus-like Chronic Graft Versus Host Disease
- Abstract Number: 1700
Laser Speckle Contrast Analysis in the Follow-up of Digital Ulcers in Systemic Sclerosis Patients
- Abstract Number: 477
Leflunomide Use Is Not Associated with an Increased Risk of Lung Disease in Rheumatoid Arthritis: A Meta-Analysis of Randomised Controlled Trials
- Abstract Number: 1696
Left Atrial Area Measurement Is Useful for Evaluating Left Ventricular Diastolic Dysfunction Coexisting with Pulmonary Arterial Hypertension Associated with Systemic Sclerosis
- Abstract Number: 200
Leg Length Inequality and Hip Osteoarthritis
- Abstract Number: 1025
Leptin Production By Osteoarthritis Synovial Fibroblasts: Stimulation By Glucocorticoids and Mineralocorticoids through the Glucocorticoid Receptor and GILZ (Glucocorticoid-Induced Leucine Zipper) Protein
- Abstract Number: L10
Lesinurad, a Novel Selective Uric Acid Reabsorption Inhibitor, in Two Phase III Clinical Trials: Combination Study of Lesinurad in Allopurinol Standard of Care Inadequate Responders (CLEAR 1 and 2)
- Abstract Number: 420
Less Is More: The Shorter Physical Function Measure Promis-PF10a Outperforms HAQ in an Ethnically Diverse, Urban Rheumatoid Arthritis Clinic Population
- Abstract Number: 2363
Leucine-Rich Alpha-2 Glycoprotein Is a Potential Disease Activity Marker Under IL-6 Suppression in Autoimmune Arthritis
- Abstract Number: 1058
Levels of Fatigue Are Dependent on Country of Residence in Rheumatoid Arthritis: An Analysis Among 3920 Patients from 17 Countries
- Abstract Number: 387
Levels of IgG Autoantibodies to Oxidation-Associated MDA Neo-Determinants Are a Biomarker for Systemic Inflammation and Disease Activity in SLE and RA
- Abstract Number: 1346
Leveraging Electronic Health Records to Improve Vaccination Rates for Patients with Rheumatoid Arthritis
- Abstract Number: 2351
Ligand of Glucocorticoid-Induced Tumor Necrosis Factor Receptor Enhances Th17 Cells Response in Collagen-Induced Arthritis Via P38 MAPK and STAT3 Pathway
- Abstract Number: 2137
Linear Extrapolation of Missing Radiographic Progression Scores Does Not Spuriously overestimate overall Radiographic Progression in Rheumatoid Arthritis
- Abstract Number: 399
Lipid Concentrations and Particle Sizes in Drug Naive Patients with Rheumatoid Arthritis
- Abstract Number: 841
Lipid Control and Cardiovascular Risk for Patients with Rheumatoid Arthritis Compared with Matched Non-Rheumatoid Arthritis Patients
- Abstract Number: 636
Liposomal-Glucocorticoids: A Novel Approach to the Therapy of SLE
- Abstract Number: 92
Long Noncoding RNA Nron Regulates the Activity of NFAT5 through Ubiquitin-Independent Proteasome Pathway in Rheumatoid Arthritis
- Abstract Number: 293
Long Term Functional Outcome and Quality of Life of Patients with Refractory Juvenile Idiopathic Arthritis Treated with Etanercept: Results of the Dutch Arthritis and Biologicals in Children Register
- Abstract Number: 1559
Long Term Improvements in Physical Function Are Associated with Improvements in Dactylitis, Enthesitis, Tender and Swollen Joint Counts, and Psoriasis Skin Involvement: Results from a Phase 3 Study of Ustekinumab in Psoriatic Arthritis Patients
- Abstract Number: 1245
Long Term Outcome of Infliximab in Severe and Refractory Systemic Sarcoidosis: Report of 16 Cases
- Abstract Number: 913
Long Term Outcomes of Patients with Moderate Creatine Kinase (CK) Elevation Seen in a Rheumatology Clinic
- Abstract Number: 174
Long Term Safety and Efficacy of Canakinumab Liquid Formulation in Acute Gouty Arthritis Patients: Results from a 36 Week Extension Study
- Abstract Number: 479
Long Term Safety of Intravenous Golimumab and Comparison with Subcutaneous Golimumab in Rheumatoid Arthritis: Results through 2 Years
- Abstract Number: L22
Long-Term (104-Week) Safety and Efficacy of Monotherapy with Apremilast in DMARD-Naïve Patients with Psoriatic Arthritis: A Phase 3, Randomized, Controlled Trial and Open-Label Extension (PALACE 4)
- Abstract Number: 1564
Long-Term (104-Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase 3, Randomized, Controlled Trial and Open-Label Extension
- Abstract Number: 2517
Long-Term Clinical, Structural, and Functional Consequences of Not Adopting Treatment in MTX Suboptimal Responders
- Abstract Number: 2645
Long-Term Efficacy and Safety of Pulse Cyclophosphamide for Neuropsychiatric Systemic Lupus Erythematosus: A Two-Centre Experience
- Abstract Number: 1674
Long-Term Efficacy of Rituximab in Systemic Sclerosis
- Abstract Number: 957
Long-Term Evaluation of NT-Probnp Levels in Ankylosing Spondylitis Patients Under TNF Blockers: A Marker of Persistent Disease Activity?
- Abstract Number: 1782
Long-Term Follow-up of Non-HBV Polyarteritis Nodosa and Microscopic Polyangiitis with Poor-Prognosis Factors
- Abstract Number: 298
Long-Term Impact of Juvenile Idiopathic Arthritis in the Greek adults’ Psychosocial Life
- Abstract Number: 49
Long-Term Oral Bisphosphonate Use for Osteoporosis Among Older Women – US and Canadian Perspective
- Abstract Number: 2763
Long-Term Outcome of Chronic Progressive Neurological Manifestations in Behcet’s Disease
- Abstract Number: 1781
Long-Term Outcomes Among Patients with Renal Disease Secondary to ANCA-Associated Vasculitis: Temporal Trends over 25 Years
- Abstract Number: 813
Long-Term Outcomes of Takayasu’s Arteritis Patients with Renal Artery Involvement
- Abstract Number: 294
Long-Term Pharmacokinetics of Body Surface Area-Adjusted Doses of Golimumab Following Repeated Subcutaneous Administrations in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis
- Abstract Number: 1159
Long-Term Quality of Life, Productivity Impairment, Disease Severity and Health Care Costs in Relation to Functional Impairment in Ankylosing Spondylitis Patients in the Czech Republic
- Abstract Number: 273
Long-Term Safety and Effectiveness of Adalimumab in Children with Moderately to Severely Active Polyarticular or Polyarticular-Course Juvenile Idiopathic Arthritis
- Abstract Number: 545
Long-Term Safety and Efficacy of Certolizumab Pegol over 96 Weeks in Patients with Psoriatic Arthritis with and without Prior Tumor Necrosis Factor Inhibitor Exposure
- Abstract Number: 2505
Long-Term Treatment with Tocilizumab (TCZ) Strongly Suppresses Joint Destruction in Biologic-naïve Patients with Rheumatoid Arthritis (RA) Regardless of Inflammation Status
- Abstract Number: 262
Longitudinal Assessment of Promis Pediatric Item Banks in Children with Chronic Musculoskeletal Pain
- Abstract Number: 2931
Longitudinal Examination with Salivary Gland Ultrasonography (SGUS) of Patients with Primary Sjogren’s Syndrome: A Single Center Experience
- Abstract Number: 1724
Loss of IRF5 Ameliorates Tissue Fibrosis in a Murine Model of Systemic Sclerosis
- Abstract Number: 2907
Loss of microRNA-146a Exacerbates Inflammatory Arthritis
- Abstract Number: 2561
Low Cardio-Respiratory Fitness Is Associated with Increased Arterial Stiffness in Patients with Ankylosing Spondylitis
- Abstract Number: 1206
Low Dose Colchicine Anti-Inflammatory Effects Are Transduced By AMP-Activated Protein Kinase (AMPK)
- Abstract Number: 1407
Low HAQ and Pain Predict Patient Perceived Remission in Rheumatoid Arthritis Patients Receiving MTX or Anti-TNF-Alpha Treatment
- Abstract Number: 1427
Low Prevalence of Sarcopenic Obesity in Rheumatoid Arthritis Patients with Moderate Clinical Activity
- Abstract Number: L3
Low Protein A20 Expression in Minor Salivary Glands Is Associated with Lymphoma Development in Primary Sjögren’s Syndrome
- Abstract Number: 111
Low Rates of Bone Mineral Density Testing in Medicare Beneficiaries with Breast Cancer Starting Aromatase Inhibitor Therapy
- Abstract Number: 1410
Low Rates of Cardiovascular Risk Factor Modification Among High-Risk Rheumatoid Arthritis Patients: Barrier to Cardiovascular Prevention Strategies?
- Abstract Number: 2619
Low Socioeconomic Status (SES) As Measured By Education Is (not) Associated with Worse Outcome in SLE: Data from the 1000 Canadian Faces of Lupus
- Abstract Number: 1394
Low Vitamin D Level Is Not Associated with Increased Risk of Cardiovascular Disease in Rheumatoid Arthritis Patients
- Abstract Number: 220
Lower Extremity Presarcopenia Is Associated with the Severity of Knee Pain
- Abstract Number: 235
Lower P1NP Serum Levels: a Predictive Marker of Bone Loss after One-Year Follow-up in premenopausal SLE Patients
- Abstract Number: 2118
Lower Socioeconomic Status at Disease Onset Is Associated with Higher Health Care Costs in Patients with Systemic Lupus Erythematosus: A General Population-Based Cohort Study
- Abstract Number: 734
Lower Socioeconomic Status, Male Gender and Diffuse Scleroderma Are Associated with Worse Survival in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Cohort
- Abstract Number: 878
Luminex and Autoantigen Microarray Analysis of Sera from Patients with Diffuse Cutaneous Systemic Sclerosis Reveals Changes Associated with Imatinib Mesylate Treatment
- Abstract Number: 2791
Lung Cancer in SLE
- Abstract Number: 2976
Lung Ultrasound Screening for Interstitial Lung Disease in Rheumatoid Arthritis. Comparison with Usual Detection Algorithms in Clinical Practice
- Abstract Number: 705
Lupus Chest Pain in the Emergency Department: a Common Diagnostic Dilemma
- Abstract Number: 2989
Lupus Impact Tracker Is Responsive to Changes in Disease Activity in Lupus
- Abstract Number: 694
Lupus Myocarditis: Clinical, Echocardiographic and Magnetic Resonance Characteristics
- Abstract Number: 1311
Lupus Nephritis in Mexican Children
- Abstract Number: 1662
Lupus Nephritis Patients Who Stopped Maintenance Immunosuppressive Therapy without Relapse
- Abstract Number: 1655
Lupus Nephritis: Clinicopathological Correlation in 126 Biopsies
- Abstract Number: 690
Lupus Patients Requiring First Corticosteroid Intervention Late in Disease Course – a Phenotypic Description
- Abstract Number: 713
Lupuspro Is Responsive to Changes in Disease Activity over Time
- Abstract Number: 1
Lymphocyte Proliferation to a Cross-Reactive Gut Commensal Candidate in Antiphospholipid Syndrome
2014 ACR/ARHP Annual Meeting
November 14-19, 2014. Boston, MA.